Martin Edelman, MD, Talks About Improving Outcomes in the Management of NSCLC

About Us

Publications

AJMC TV

Events

Conferences

News

Authors

Essentials

Research

ACO Coalition

NAMCP Spring 2013

Martin Edelman, MD, Talks About Improving Outcomes in the Management of NSCLC

Martin Edelman, MD, Greenbaum Cancer Center, Baltimore, MD, says that organizations like NCCN and ASCO have guidelines for the management of non-small cell lung cancer (NSCLC). "I think that by utilizing these various clinical as well as biological markers, we can develop therapies that are tailored to the individual patient and have substantial evidence to support their use," said Dr Edelman.

This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.

More on AJMC.COM

Innovative Approaches by Pharmacists Save Costs at a Comprehensive Cancer Center

Active implementation of cost-saving measures successfully cut down expenditure at the Norris Comprehensive Cancer Center.

Without Medicaid,Hospitals May Pay Patient Premiums

Uncompensated care was supposed to be a thing of the past, but it's persisting in many states not expanding Medicaid eligibility. As an alternative, for some high-cost uninsured patients, hospitals are turning to a new option.

For Better Treatment, Doctors And Patients Share The Decisions

When weighing the risk of heart disease, how the numbers are presented to patients can make all the difference.

BMS Announces Collaboration With Ono Pharmaceutical to Market Opdivo

Opdivo (Nivolumab) recently received regulatory approval in Japan for the treatment of patients with unresectable melanoma, the first global approval for a PD-1 inhibitor.

CDC Lab Safety Point Person, Dr. Michael Bell, to Give Keynote on Hospital Safety at AJMCLive Event

Dr. Michael Bell, previously announced as the keynote speaker for the September 25-26 live meeting hosted by The American Journal of Managed Care, this weekend discussed his role in overhauling lab safety at the Centers for Disease Control and Prevention in Atlanta. Attendees at AJMCLive’s Atlanta conference, “Value-Based Decision-Making in Infectious Disease,” will have the chance to hear Dr. Bell discuss the prevention of hospital-acquired infections.

Robotics Do Not Reduce Complications in Bladder Surgery

Following the success of robotics in prostate surgeries, the technique was expected to provide comparable results for bladder cancer surgeries as well.

Gilead's Idelalisib Approved for CLL and Lymphoma

The drug has been approved for use in patient's with relapsed disease.